Kambiz Yazdi
Stock Analyst at BTIG
(3.00)
# 361
Out of 5,182 analysts
22
Total ratings
90.91%
Success rate
29.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Reiterates: Buy | $843 | $340.84 | +147.33% | 6 | Apr 6, 2026 | |
| ZVRA Zevra Therapeutics | Initiates: Buy | $23 | $10.39 | +121.37% | 1 | Mar 16, 2026 | |
| RAPP Rapport Therapeutics | Maintains: Buy | $47 → $53 | $36.95 | +43.44% | 3 | Mar 11, 2026 | |
| VTVT vTv Therapeutics | Reiterates: Buy | $49 | $38.30 | +27.94% | 3 | Mar 11, 2026 | |
| SION Sionna Therapeutics | Reiterates: Buy | $58 | $41.79 | +38.79% | 4 | Mar 2, 2026 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $14.29 | +60.95% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $23.40 | -18.80% | 2 | Mar 11, 2025 | |
| EYPT EyePoint | Initiates: Buy | $15 | $14.11 | +6.31% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.46 | +242.47% | 1 | Apr 12, 2024 |
Praxis Precision Medicines
Apr 6, 2026
Reiterates: Buy
Price Target: $843
Current: $340.84
Upside: +147.33%
Zevra Therapeutics
Mar 16, 2026
Initiates: Buy
Price Target: $23
Current: $10.39
Upside: +121.37%
Rapport Therapeutics
Mar 11, 2026
Maintains: Buy
Price Target: $47 → $53
Current: $36.95
Upside: +43.44%
vTv Therapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $49
Current: $38.30
Upside: +27.94%
Sionna Therapeutics
Mar 2, 2026
Reiterates: Buy
Price Target: $58
Current: $41.79
Upside: +38.79%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $14.29
Upside: +60.95%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $23.40
Upside: -18.80%
EyePoint
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $14.11
Upside: +6.31%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.46
Upside: +242.47%